Loading provider…
Loading provider…
Neurology Physician in Chicago, IL
NPI: 1295712545Primary Practice Location
RUSH UNIVERSITY MEDICAL CENTER
1620 W Harrison St, Chicago, IL
Primary Employer
Rush University Internists
rush.edu
HQ Phone
Get MD Aikaterini's Phone Numberphone_androidMobile
Get MD Aikaterini's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardIL State Medical License
IL State Medical License
1993 - 2026

American Board of Psychiatry and Neurology
Neurology
Rush University Medical Center
Residency • Neurology
1995 - 1998
McGaw Medical Center of Northwestern University
Residency • Neurology
1992 - 1995
Ascension Illinois/Saint Francis
Residency • Internal Medicine
1990 - 1992
University of Patras School of Medicine
Medical School
Until 1988
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 145 | 220 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 89 | 123 |
| 3 | 95874Needle measurement and recording of electrical activity of muscles for guidance with injection of chemical for destruction of muscles | 65 | 160 |
| 4 | 64616Injection of chemical for destruction of nerve muscles on one side of neck excluding voice box accessed through the skin | 45 | 118 |
| 5 | 99205New patient office or other outpatient visit, typically 60 minutes | 27 | 27 |
Human T-cell lymphotropic virus type 1-associated myelopathy, Sjögren syndrome, and lymphocytic pneumonitis.
Authors: Blondell Gage
H reflex in S-1 radiculopathy: latency versus amplitude controversy revisited.
Authors: Takashi Nishida, Aikaterini Kompoliti, Ian Janssen, Karen F. Levin
Publication Date: 1996-07
Lead Sponsor: AEON Biopharma, Inc.
Collaborators: PPD Development, LP
Intervention / Treatment: DRUG: Placebo, DRUG: ABP-450
Lead Sponsor: Emalex Biosciences Inc.
Intervention / Treatment: DRUG: Ecopipam
Lead Sponsor: Neurocrine Biosciences
Intervention / Treatment: DRUG: Placebo oral capsule, DRUG: Valbenazine